SG152265A1 - Aerosol formulation for inhalation of beta agonists - Google Patents
Aerosol formulation for inhalation of beta agonistsInfo
- Publication number
- SG152265A1 SG152265A1 SG200902777-2A SG2009027772A SG152265A1 SG 152265 A1 SG152265 A1 SG 152265A1 SG 2009027772 A SG2009027772 A SG 2009027772A SG 152265 A1 SG152265 A1 SG 152265A1
- Authority
- SG
- Singapore
- Prior art keywords
- inhalation
- aerosol formulation
- beta agonists
- agonists
- beta
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/536—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with carbocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/04—Amoebicides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Dispersion Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Dermatology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102004024452A DE102004024452A1 (de) | 2004-05-14 | 2004-05-14 | Aerosolformulierung für die Inhalation von Betaagonisten |
Publications (1)
Publication Number | Publication Date |
---|---|
SG152265A1 true SG152265A1 (en) | 2009-05-29 |
Family
ID=34979667
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG200902777-2A SG152265A1 (en) | 2004-05-14 | 2005-05-10 | Aerosol formulation for inhalation of beta agonists |
Country Status (26)
Country | Link |
---|---|
EP (1) | EP1809293B1 (ru) |
JP (1) | JP4620730B2 (ru) |
KR (1) | KR101288791B1 (ru) |
CN (1) | CN101056640A (ru) |
AR (1) | AR049096A1 (ru) |
AU (1) | AU2005244414B2 (ru) |
BR (1) | BRPI0511135B8 (ru) |
CA (1) | CA2564379C (ru) |
DE (1) | DE102004024452A1 (ru) |
DK (1) | DK1809293T3 (ru) |
EA (1) | EA012583B1 (ru) |
EC (1) | ECSP067004A (ru) |
ES (1) | ES2575925T3 (ru) |
HU (1) | HUE027780T2 (ru) |
IL (1) | IL179218A (ru) |
MX (1) | MXPA06013216A (ru) |
MY (1) | MY148403A (ru) |
NO (1) | NO20065030L (ru) |
PE (1) | PE20060311A1 (ru) |
PL (1) | PL1809293T3 (ru) |
SG (1) | SG152265A1 (ru) |
TW (1) | TWI356703B (ru) |
UA (1) | UA87312C2 (ru) |
UY (1) | UY28891A1 (ru) |
WO (1) | WO2005110421A2 (ru) |
ZA (1) | ZA200607462B (ru) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7056916B2 (en) | 2002-11-15 | 2006-06-06 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Medicaments for the treatment of chronic obstructive pulmonary disease |
US7220742B2 (en) | 2004-05-14 | 2007-05-22 | Boehringer Ingelheim International Gmbh | Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments |
RU2412176C2 (ru) | 2005-08-15 | 2011-02-20 | Бёрингер Ингельхайм Интернациональ Гмбх | Способ получения бетамиметиков |
BRPI0618370A2 (pt) * | 2005-11-09 | 2011-08-30 | Boehringer Ingelheim Int | formulação aerossol de medicamento, uso do mesmo e kit de inalação |
UY30543A1 (es) * | 2006-08-18 | 2008-03-31 | Boehringer Ingelheim Int | Formulacion de aerosol para la inhalacion de beta- agonistas |
JP2012509298A (ja) * | 2008-11-21 | 2012-04-19 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | β作用薬吸入用のエアロゾル製剤 |
CA2738617A1 (en) * | 2008-11-21 | 2011-05-27 | Boehringer Ingelheim International Gmbh | Aerosol formulation for the inhalation of beta agonists |
JP2015533131A (ja) | 2012-10-09 | 2015-11-19 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 咳を治療するためのベータ2−アドレナリン受容体作動薬 |
CN110062625A (zh) | 2016-12-12 | 2019-07-26 | 勃林格殷格翰国际有限公司 | 尼达尼布通过与奥达特罗共给予用于治疗间质性肺病的方法 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3134590A1 (de) * | 1981-09-01 | 1983-03-10 | Boehringer Ingelheim KG, 6507 Ingelheim | Neue benzo-heterocyclen |
US4460581A (en) * | 1982-10-12 | 1984-07-17 | Boehringer Ingelheim Kg | (1-Hydroxy-2-amino-alkyl)-substituted benzoxazinones and benzoxazolinones |
JPH0637388B2 (ja) * | 1986-02-17 | 1994-05-18 | 千寿製薬株式会社 | 水性液剤 |
GB9405019D0 (en) * | 1994-03-15 | 1994-04-27 | Smithkline Beecham Plc | Novel compounds |
DE10253282A1 (de) * | 2002-11-15 | 2004-05-27 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Arzneimittel zur Behandlung von chronisch obstruktiver Lungenerkrankung |
BRPI0510080B8 (pt) * | 2004-04-22 | 2021-05-25 | Boehringer Ingelheim Int | combinação farmacêutica e seu uso |
DE102004019539A1 (de) * | 2004-04-22 | 2005-11-10 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Arzneimittel zur Behandlung von Atemwegserkrankungen |
DE102004024454A1 (de) * | 2004-05-14 | 2005-12-08 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Enantiomerenreine Betaagonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel |
DE102004024451A1 (de) * | 2004-05-14 | 2005-12-22 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Pulverformulierungen für die Inhalation, die Enantiomerenreine Betaagonisten enthalten |
-
2004
- 2004-05-14 DE DE102004024452A patent/DE102004024452A1/de not_active Withdrawn
-
2005
- 2005-05-10 ES ES05747843.0T patent/ES2575925T3/es active Active
- 2005-05-10 EA EA200602017A patent/EA012583B1/ru not_active IP Right Cessation
- 2005-05-10 SG SG200902777-2A patent/SG152265A1/en unknown
- 2005-05-10 BR BRPI0511135A patent/BRPI0511135B8/pt active IP Right Grant
- 2005-05-10 PL PL05747843.0T patent/PL1809293T3/pl unknown
- 2005-05-10 MX MXPA06013216A patent/MXPA06013216A/es active IP Right Grant
- 2005-05-10 HU HUE05747843A patent/HUE027780T2/en unknown
- 2005-05-10 CA CA2564379A patent/CA2564379C/en active Active
- 2005-05-10 UA UAA200612949A patent/UA87312C2/ru unknown
- 2005-05-10 AU AU2005244414A patent/AU2005244414B2/en active Active
- 2005-05-10 JP JP2007512068A patent/JP4620730B2/ja active Active
- 2005-05-10 EP EP05747843.0A patent/EP1809293B1/de active Active
- 2005-05-10 CN CNA2005800154865A patent/CN101056640A/zh active Pending
- 2005-05-10 WO PCT/EP2005/005028 patent/WO2005110421A2/de active Application Filing
- 2005-05-10 DK DK05747843.0T patent/DK1809293T3/en active
- 2005-05-10 KR KR1020067026225A patent/KR101288791B1/ko active IP Right Grant
- 2005-05-11 UY UY28891A patent/UY28891A1/es not_active Application Discontinuation
- 2005-05-12 PE PE2005000529A patent/PE20060311A1/es not_active Application Discontinuation
- 2005-05-12 MY MYPI20052158A patent/MY148403A/en unknown
- 2005-05-13 TW TW094115491A patent/TWI356703B/zh not_active IP Right Cessation
- 2005-05-13 AR ARP050101959A patent/AR049096A1/es unknown
-
2006
- 2006-09-06 ZA ZA200607462A patent/ZA200607462B/en unknown
- 2006-11-02 NO NO20065030A patent/NO20065030L/no not_active Application Discontinuation
- 2006-11-13 EC EC2006007004A patent/ECSP067004A/es unknown
- 2006-11-13 IL IL179218A patent/IL179218A/en active IP Right Grant
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20180713T1 (hr) | Aerosolna formulacija za inhaliranje beta-agonista | |
IL197024A0 (en) | Aerosol formulation for the inhalation of beta agonists | |
IL197025A0 (en) | Aerosol formulation for the inhalation of beta agonists | |
IL179218A0 (en) | Aerosol formulation for inhalation of beta agonists | |
GB0525254D0 (en) | Powder compositions for inhalation | |
IL174496A0 (en) | Aerosol formulation for inhalation, containing an anticholinergic agent | |
EP1993646A4 (en) | CONFIGURATION OF NOZZLE PORES FOR INTRA-PULMONARY ADMINISTRATION OF AEROSOL FORMULATIONS | |
DK1809236T3 (da) | Pulverformuleringer til inhalation indeholdende enatiomeriske rene beta-agonister | |
EP1806148A4 (en) | THERAPEUTIC PREPARATION FOR INHALATION | |
IL198854A0 (en) | Powder formulation for valganciclovir | |
GB0416328D0 (en) | Use of dry powder compositions for pulmonary delivery | |
IL183930A0 (en) | Use of cladribine for preparation of pharmaceutical compositions | |
ZA200806929B (en) | Nebulizer formulation | |
ZA200704977B (en) | Nebulizer formulation | |
SI1496876T1 (sl) | Aerosolna formulacija za inhalacijo, ki vsebuje tiotropijev bromid | |
ZA200900370B (en) | Aerosol formulation for the inhalation of beta agonists | |
ATE401861T1 (de) | Tiotropiumhaltige pulverformulierung für die inhalation | |
EP2086943A4 (en) | NEW COMPOUNDS, THEIR PHARMACEUTICAL COMPOSITIONS AND METHODS OF APPLICATION | |
PL2167042T3 (pl) | Kompozycje farmaceutyczne w aerozolu zawierające flutykazon | |
EP1931327A4 (en) | CYCLOPROPYL COMPOUNDS AND COMPOSITIONS FOR THE DISPOSAL OF ACTIVE SUBSTANCES | |
ZA200900418B (en) | Aerosol formulation for the inhalation of beta agonists | |
AP2006003734A0 (en) | Inhalation formulation | |
ZA200606181B (en) | Aerosol formulation | |
GB0519083D0 (en) | Compositions for the improved delivery of medicaments | |
PL371710A1 (pl) | Środek do zwalczania zagrożeń pyłowych |